Loading...
1470 logo

evertex fabrinology limitedTWSE:1470 Stock Report

Market Cap NT$2.0b
Share Price
n/a
1Y16.7%
7D1.7%
1D0%
Portfolio Value
​
View

evertex fabrinology limited

TWSE:1470 Stock Report

Market Cap: NT$2.0b

evertex fabrinology (1470) Stock Overview

Engages in dyeing and finishing of textile products in Taiwan, Vietnam, Bengal, China, Cambodia, Indonesia, and internationally. More details

1470 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 30.8% below our estimate of its fair value

Earnings grew by 128.3% over the past year

Risk Analysis

Unstable dividend track record

Does not have a meaningful market cap (NT$2B)


1470 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW463,021 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
463,021 investors already sharing narratives
View all narratives

evertex fabrinology limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for evertex fabrinology
Historical stock prices
Current Share PriceNT$23.70
52 Week HighNT$24.60
52 Week LowNT$19.55
Beta0.13
1 Month Change5.10%
3 Month Change7.73%
1 Year Change16.75%
3 Year Change23.44%
5 Year Change37.79%
Change since IPO43.70%

Recent News & Updates

Recent updates

Analysis Article • Nov 19

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Despite posting some strong earnings, the market for evertex fabrinology limited's ( TWSE:1470 ) stock hasn't moved...
Analysis Article • Sep 16

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology limited's ( TWSE:1470 ) price-to-earnings (or "P/E") ratio of 32.9x might make it look like a...
Analysis Article • Mar 20

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

evertex fabrinology limited's ( TWSE:1470 ) stock didn't jump after it announced some healthy earnings. We think that...
Analysis Article • Apr 25

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Is evertex fabrinology limited ( TPE:1470 ) a good dividend stock? How can we tell? Dividend paying companies with...
Analysis Article • Mar 26

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Analysis Article • Mar 05

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

evertex fabrinology's (TPE:1470) stock is up by 3.1% over the past month. However, its weak financial performance...
Analysis Article • Feb 12

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Analysis Article • Jan 25

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Dividend paying stocks like evertex fabrinology limited ( TPE:1470 ) tend to be popular with investors, and for good...
Analysis Article • Jan 07

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. While...
Analysis Article • Dec 20

Is evertex fabrinology (TPE:1470) Headed For Trouble?

If you're looking at a mature business that's past the growth phase, what are some of the underlying trends that pop...
Analysis Article • Dec 02

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

evertex fabrinology's (TPE:1470) stock is up by 2.0% over the past week. However, its weak financial performance...

Shareholder Returns

1470TW LuxuryTW Market
7D1.7%0.2%-2.5%
1Y16.7%-16.0%85.0%

Return vs Industry: 1470 exceeded the TW Luxury industry which returned -16% over the past year.

Return vs Market: 1470 underperformed the TW Market which returned 85% over the past year.

Price Volatility

Is 1470's price volatile compared to industry and market?
1470 volatility
1470 Average Weekly Movement3.5%
Luxury Industry Average Movement4.3%
Market Average Movement6.4%
10% most volatile stocks in TW Market11.9%
10% least volatile stocks in TW Market2.7%

Stable Share Price: 1470 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 1470's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aAnthony Yehwww.evertex.tw

evertex fabrinology limited engages in dyeing and finishing of textile products in Taiwan, Vietnam, Bengal, China, Cambodia, Indonesia, and internationally. The company offers Janerino, a hybrid merino wool fabric; BulkyStretch, a mono-material knit fabric; Syncellux, a cellulose synthetic blend fabric; and Tonissimo, a synthetic fleece fabric. It also provides functional fabrics; and fabrics for trims, pocket, and collar liners, as well as linings for casual and outdoor wears.

evertex fabrinology limited Fundamentals Summary

How do evertex fabrinology's earnings and revenue compare to its market cap?
1470 fundamental statistics
Market capNT$2.03b
Earnings (TTM)NT$111.43m
Revenue (TTM)NT$762.71m
18.2x
P/E Ratio
2.7x
P/S Ratio

Is 1470 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1470 income statement (TTM)
RevenueNT$762.71m
Cost of RevenueNT$562.34m
Gross ProfitNT$200.37m
Other ExpensesNT$88.94m
EarningsNT$111.43m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)1.30
Gross Margin26.27%
Net Profit Margin14.61%
Debt/Equity Ratio2.5%

How did 1470 perform over the long term?

See historical performance and comparison

Dividends

2.7%
Current Dividend Yield
50%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/21 16:05
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

evertex fabrinology limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.